From RPPA data we performed a hierarchical cluster analysis considering the JAK1/2-STAT6 pathway in T-LBL cases based on good and poor prognosis and 13 commercially available leukemia cell lines (Figure S3A). This evidence concerns the gene JAK1 and leukemia.